IMPACT OF OPIOID DEPRESCRIBING AND TAPERING ON MENTAL HEALTH AND SOCIAL FUNCTIONING IN PATIENTS WITH CHRONIC NON – CANCER PAIN: AN OVERVIEW OF CURRENT EVIDENCE

Authors

DOI:

https://doi.org/10.31435/ijitss.3(51).2026.5934

Keywords:

Mental Health; Depression; Chronic Pain; Pain Management; Opioid Crisis

Abstract

Background. Long-term opioid therapy for chronic non-cancer pain is associated with numerous adverse effects, including psychological distress, dependence, and impaired functioning. In response to growing concerns about opioid-related harms, opioid deprescribing and tapering strategies have gained increasing attention in clinical practice. However, their impact on patients’ mental health and social functioning remains incompletely understood.

Aim. This review aimed to evaluate the available evidence on the effects of opioid deprescribing and tapering on mental health and social functioning in patients with chronic non-cancer pain.

Material and methods. A literature review was conducted using major biomedical databases, including PubMed, MEDLINE, Scopus, Web of Science, and the Cochrane Library. Eligible studies included peer-reviewed articles examining opioid deprescribing or tapering in adults with chronic non-cancer pain and reporting outcomes related to mental health, social functioning, or patient-reported functioning

Results. The available evidence suggests that patients undergoing opioid deprescribing frequently present with substantial psychological distress, including depression, anxiety, and pain catastrophizing. Mental health outcomes during tapering are heterogeneous and influenced by the pace of dose reduction, patient involvement in decision making, and access to psychological support. Qualitative studies commonly highlight social factors: stigma, communication with healthcare providers, and availability of alternative pain management strategies.

Conclusions. Opioid deprescribing in patients with chronic non-cancer pain represents a complex clinical process with potential implications for both mental health and social functioning. Individualized tapering strategies, patient involvement in treatment decisions, and adequate psychological and multidisciplinary support appear essential for minimizing adverse outcomes and improving patient experiences during opioid dose reduction.

References

Benintendi, A., Kosakowski, S., Lagisetty, P., Larochelle, M., Bohnert, A. S. B., & Bazzi, A. R. (2021). “I felt like I had a scarlet letter”: Recurring experiences of structural stigma surrounding opioid tapers among patients with chronic, non-cancer pain. Drug and Alcohol Dependence, 222, 108664. https://doi.org/10.1016/j.drugalcdep.2021.108664

Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022). CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recommendations and Reports, 71(3), 1–95. https://doi.org/10.15585/mmwr.rr7103a1

Eccleston, C., Fisher, E., Thomas, K. H., Hearn, L., Derry, S., Stannard, C., Knaggs, R., & Moore, R. A. (2017). Interventions for the reduction of prescribed opioid use in chronic non-cancer pain. Cochrane Database of Systematic Reviews, 2017(11), CD010323. https://doi.org/10.1002/14651858.CD010323.pub3

Elman, I., Borsook, D., & Volkow, N. D. (2013). Pain and suicidality: Insights from reward and addiction neuroscience. Progress in Neurobiology, 109, 1–27. https://doi.org/10.1016/j.pneurobio.2013.06.003

Els, C., Jackson, T. D., Hagtvedt, R., Kunyk, D., Sonnenberg, B., Lappi, V. G., & Straube, S. (2023). High-dose opioids for chronic non-cancer pain: An overview of Cochrane Reviews. Cochrane Database of Systematic Reviews, 2023(3), CD012299. https://doi.org/10.1002/14651858.CD012299.pub3

Hamilton, M., Gnjidic, D., Lin, C.-W. C., Jansen, J., Weir, K. R., Ahaheed, C. A., Blyth, F., & Mathieson, S. (2022). Opioid deprescribing: Qualitative perspectives from those with chronic non-cancer pain. Research in Social and Administrative Pharmacy, 18(12), 4083–4091. https://doi.org/10.1016/j.sapharm.2022.07.043

Hickling, L. M., Allani, S., Cella, M., & Scott, W. (2024). A systematic review with meta-analyses of the association between stigma and chronic pain outcomes. Pain, 165(8), 1689–1701. https://doi.org/10.1097/j.pain.0000000000003243

Hooley, J. M., Franklin, J. C., & Nock, M. K. (2014). Chronic pain and suicide: Understanding the association. Current Pain and Headache Reports, 18, 435. https://doi.org/10.1007/s11916-014-0435-2

Hooten, W. M. (2016). Chronic pain and mental health disorders: Shared neural mechanisms, epidemiology, and treatment. Mayo Clinic Proceedings, 91(7), 955–970. https://doi.org/10.1016/j.mayocp.2016.04.029

Kwon, C.-Y., & Lee, B. (2023). Prevalence of suicidal behavior in patients with chronic pain: A systematic review and meta-analysis of observational studies. Frontiers in Psychology, 14, 1217299. https://doi.org/10.3389/fpsyg.2023.1217299

Langford, A. V., Lin, C. C. W., Bero, L., Blyth, F. M., Doctor, J., Holliday, S., Jeon, Y.-H., Moullin, J., Murnion, B., Nielsen, S., Osman, R., Penm, J., Reeve, E., Reid, S., Wale, J., Schneider, C. R., & Gnjidic, D. (2023). Clinical practice guideline for deprescribing opioid analgesics: Summary of recommendations. The Medical Journal of Australia, 219(2), 80–89. https://doi.org/10.5694/mja2.52002

Lee, Y. K., Gold, M. S., Blum, K., Thanos, P. K., Hanna, C., & Fuehrlein, B. S. (2024). Opioid use disorder: Current trends and potential treatments. Frontiers in Public Health, 11, 1274719. https://doi.org/10.3389/fpubh.2023.1274719

McNeilage, A. G., Avery, N. S., Holliday, S., Glare, P. A., & Ashton-James, C. E. (2022). A qualitative trajectory analysis of patients’ experiences tapering opioids for chronic pain. Pain, 163(2), 246–260. https://doi.org/10.1097/j.pain.0000000000002336

Quinlan, J., Willson, H., & Grange, K. (2021). Hopes and fears before opioid tapering: A quantitative and qualitative study of patients with chronic pain and long-term opioids. British Journal of Pain, 15(2), 120–128. https://doi.org/10.1177/2049463720974053

Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. (2020). Opioid use disorder. Nature Reviews Disease Primers, 6, 3. https://doi.org/10.1038/s41572-019-0137-5

Treede, R.-D., Rief, W., Barke, A., Aziz, Q., Bennett, M. I., Benoliel, R., Cohen, M., Evers, S., Finnerup, N. B., First, M. B., Giamberardino, M. A., Kaasa, S., Kosek, E., Lavand’homme, P., Nicholas, M., Perrot, S., Scholz, J., Schug, S., Smith, B. H., Svensson, P., Vlaeyen, J. W. S., & Wang, S.-J. (2015). A classification of chronic pain for ICD-11. Pain, 156(6), 1003–1007. https://doi.org/10.1097/j.pain.0000000000000160

Wilson, K. G., Kowal, J., Henderson, P. R., McWilliams, L. A., & Péloquin, K. (2013). Chronic pain and the interpersonal theory of suicide. Rehabilitation Psychology, 58(1), 111–115. https://doi.org/10.1037/a0031390

Wołoszyn, B., Rzeźnik, P., Sobczyk, M., Stachera, W., Guzowska, J., Chajnowska, A., Borowy, A., Suchcicka, W., Zach, M., & Stępień, J. (2025). Chronic pain and depression: Correlation and treatment—A review of current literature. Quality in Sport, 43, 61351. https://doi.org/10.12775/QS.2025.43.61351

Yarborough, B. J. H., Stumbo, S. P., Schneider, J. L., Ahmedani, B. K., Daida, Y. G., Hooker, S. A., Lapham, G. T., Negriff, S., & Rossom, R. C. (2024). Patient perspectives on mental health and pain management support needed versus received during opioid deprescribing. The Journal of Pain, 25(7), 104485. https://doi.org/10.1016/j.jpain.2024.01.350

Yarborough, B. J. H., Stumbo, S. P., Schneider, J. L., Ahmedani, B. K., Daida, Y. G., Hooker, S. A., Negriff, S., Rossom, R. C., & Lapham, G. (2024). Impact of opioid dose reductions on patient-reported mental health and suicide-related behavior and relationship to patient choice in tapering decisions. The Journal of Pain, 25(4), 1094–1105. https://doi.org/10.1016/j.jpain.2023.11.002

Downloads

Published

2026-08-28

How to Cite

Wnęk, M., Łebek, M. A., Komornik, W. Z., Piec, J. J., Grębosz, D., Kukiełka, W., Sałapski, B. A., Brożyna, D. W., Dudek, J., & Gałwiaczek, J. D. (2026). IMPACT OF OPIOID DEPRESCRIBING AND TAPERING ON MENTAL HEALTH AND SOCIAL FUNCTIONING IN PATIENTS WITH CHRONIC NON – CANCER PAIN: AN OVERVIEW OF CURRENT EVIDENCE. International Journal of Innovative Technologies in Social Science, 2(3(51). https://doi.org/10.31435/ijitss.3(51).2026.5934

Most read articles by the same author(s)